{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:24:45Z","timestamp":1791282285439,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["22591721"],"award-info":[{"award-number":["22591721"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012412","name":"Kansai Medical University","doi-asserted-by":"crossref","award":["B-9"],"award-info":[{"award-number":["B-9"]}],"id":[{"id":"10.13039\/501100012412","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.brainres.2011.02.079","type":"journal-article","created":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T20:29:31Z","timestamp":1299529771000},"page":"125-133","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Possible role of propofol's cyclooxygenase-inhibiting property in alleviating dopaminergic neuronal loss in the substantia nigra in an MPTP-induced murine model of Parkinson's disease"],"prefix":"10.1016","volume":"1387","author":[{"given":"Kozue","family":"Kubo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takefumi","family":"Inada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh","family":"Shingu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2011.02.079_bb0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1213\/01.ANE.0000120083.10269.54","article-title":"2,6 Di-tert-butylphenol, a nonanesthetic propofol analog, modulates alpha1beta glycine receptor function in a manner distinct from propofol","volume":"99","author":"Ahrens","year":"2004","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.brainres.2011.02.079_bb0010","doi-asserted-by":"crossref","first-page":"10635","DOI":"10.1523\/JNEUROSCI.19-24-10635.1999","article-title":"The general anesthetic propofol slows deactivation and desensitization of GABA(A) receptors","volume":"19","author":"Bai","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2011.02.079_bb0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/mds.870130205","article-title":"Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease","volume":"13","author":"Banati","year":"1998","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainres.2011.02.079_bb0020","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/86477","article-title":"COX-2 as a multifunctional neuronal modulator","volume":"7","author":"Bazan","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.brainres.2011.02.079_bb0025","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0090-6980(02)00031-X","article-title":"Prostaglandins and other lipid mediators in Alzheimer's disease","volume":"68\u201369","author":"Bazan","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.brainres.2011.02.079_bb0030","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.neurobiolaging.2008.05.017","article-title":"S100B\/RAGE-dependent activation of microglia via NF-kappaB and AP-1 Co-regulation of COX-2 expression by S100B, IL-1beta and TNF-alpha","volume":"31","author":"Bianchi","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2011.02.079_bb0035","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0006-8993(95)01189-7","article-title":"Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures","volume":"704","author":"Bronstein","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2011.02.079_bb0040","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2105\/AJPH.88.9.1337","article-title":"Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset","volume":"88","author":"Brookmeyer","year":"1998","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.brainres.2011.02.079_bb0045","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/archneur.60.8.1059","article-title":"Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease","volume":"60","author":"Chen","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.brainres.2011.02.079_bb0050","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1113\/jphysiol.2008.163923","article-title":"GABAergic activities enhance macrophage inflammatory protein-1alpha release from microglia (brain macrophages) in postnatal mouse brain","volume":"587","author":"Cheung","year":"2009","journal-title":"J. Physiol."},{"key":"10.1016\/j.brainres.2011.02.079_bb0055","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1212\/01.WNL.0000140706.52798.BE","article-title":"Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study","volume":"63","author":"de Lau","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2011.02.079_bb0060","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1093\/brain\/awl206","article-title":"Circulating monocytes engraft in the brain, differentiate into microglia and contribute to the pathology following meningitis in mice","volume":"129","author":"Djukic","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2011.02.079_bb0065","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.expneurol.2007.02.008","article-title":"Non-steroidal anti-inflammatory drugs in Parkinson's disease","volume":"205","author":"Esposito","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2011.02.079_bb0070","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/bmj.327.7407.128","article-title":"Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies","volume":"327","author":"Etminan","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.brainres.2011.02.079_bb0075","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev.neuro.22.1.219","article-title":"Microglia as mediators of inflammatory and degenerative diseases","volume":"22","author":"Gonzalez-Scarano","year":"1999","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2011.02.079_bb0080","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/0006-291X(90)90498-C","article-title":"1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles","volume":"170","author":"Hasegawa","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.brainres.2011.02.079_bb0085","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1073\/pnas.0307453101","article-title":"JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease","volume":"101","author":"Hunot","year":"2004","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.brainres.2011.02.079_bb0090","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s12630-008-9035-0","article-title":"Propofol inhibits cyclo-oxygenase activity in human monocytic THP-1 cells","volume":"56","author":"Inada","year":"2009","journal-title":"Can. J. Anaesth."},{"key":"10.1016\/j.brainres.2011.02.079_bb0095","doi-asserted-by":"crossref","first-page":"11494","DOI":"10.1073\/pnas.200357097","article-title":"gamma-Tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells","volume":"97","author":"Jiang","year":"2000","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.brainres.2011.02.079_bb0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/08923970802452046","article-title":"Propofol suppresses prostaglandin E(2) production in human peripheral monocytes","volume":"31","author":"Kambara","year":"2009","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.brainres.2011.02.079_bb0105","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.brainres.2004.09.046","article-title":"Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice","volume":"1030","author":"Kato","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2011.02.079_bb0110","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1124\/jpet.106.119206","article-title":"Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum","volume":"322","author":"Kawasaki","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2011.02.079_bb0115","doi-asserted-by":"crossref","first-page":"15069","DOI":"10.1073\/pnas.93.26.15069","article-title":"Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis","volume":"93","author":"Landino","year":"1996","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.brainres.2011.02.079_bb0120","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/glia.21087","article-title":"Astrocytes are GABAergic cells that modulate microglial activity","volume":"59","author":"Lee","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.brainres.2011.02.079_bb0125","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2011.02.079_bb0130","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1749-6632.2002.tb04077.x","article-title":"Role of nitric oxide in inflammation-mediated neurodegeneration","volume":"962","author":"Liu","year":"2002","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.brainres.2011.02.079_bb0135","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1046\/j.1460-9568.2003.02888.x","article-title":"Relationship between cyclooxygenase-2 and nitric oxide synthase-2 in rat cortex after stress","volume":"18","author":"Madrigal","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainres.2011.02.079_bb0140","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1523\/JNEUROSCI.3944-09.2010","article-title":"Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease","volume":"30","author":"Malagelada","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2011.02.079_bb0145","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1128\/JVI.66.4.2217-2225.1992","article-title":"Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1","volume":"66","author":"Merrill","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.brainres.2011.02.079_bb0150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0165-5728(97)00185-9","article-title":"Opposite regulation of prostaglandin E2 synthesis by transforming growth factor-beta1 and interleukin 10 in activated microglial cultures","volume":"82","author":"Minghetti","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.brainres.2011.02.079_bb0155","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1248\/bpb.25.945","article-title":"Regulating factors for microglial activation","volume":"25","author":"Nakamura","year":"2002","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.brainres.2011.02.079_bb0160","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1021\/tx010004x","article-title":"DNA oxidation induced by cyclooxygenase-2","volume":"14","author":"Nikolic","year":"2001","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.brainres.2011.02.079_bb0165","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1110647","article-title":"Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo","volume":"308","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.brainres.2011.02.079_bb0170","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1146\/annurev.med.55.091902.104422","article-title":"The scientific basis for the current treatment of Parkinson's disease","volume":"55","author":"Olanow","year":"2004","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.brainres.2011.02.079_bb0175","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainresrev.2006.02.002","article-title":"Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders","volume":"52","author":"Phillis","year":"2006","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.brainres.2011.02.079_bb0180","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1515\/REVNEURO.2002.13.3.221","article-title":"Reciprocal interactions between microglia and neurons: from survival to neuropathology","volume":"13","author":"Polazzi","year":"2002","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.brainres.2011.02.079_bb0185","first-page":"135","article-title":"The parkinsonian toxin MPTP: action and mechanism","volume":"16","author":"Przedborski","year":"2000","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.brainres.2011.02.079_bb0190","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/archneur.60.8.1043","article-title":"Nonsteroidal anti-inflammatory drugs protect against Parkinson neurodegeneration: can an NSAID a day keep Parkinson disease away?","volume":"60","author":"Schiess","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.brainres.2011.02.079_bb0195","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/glia.10154","article-title":"Microglia as neuroprotective, immunocompetent cells of the CNS","volume":"40","author":"Streit","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.brainres.2011.02.079_bb0240","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0165-5728(87)90121-4","article-title":"MHC antigen expression on bulk isolated macrophage-microglia from newborn mouse brain: induction of Ia antigen expression by gamma-interferon","volume":"15","author":"Suzumura","year":"1987","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.brainres.2011.02.079_bb0200","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1098-2396(200102)39:2<167::AID-SYN8>3.0.CO;2-U","article-title":"Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease","volume":"39","author":"Teismann","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.brainres.2011.02.079_bb0205","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1073\/pnas.0837397100","article-title":"Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration","volume":"100","author":"Teismann","year":"2003","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.brainres.2011.02.079_bb0210","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2174\/1568010054022051","article-title":"Prostaglandins and cyclooxygenases in glial cells during brain inflammation","volume":"4","author":"Tzeng","year":"2005","journal-title":"Curr. Drug Targets Inflamm. Allergy"},{"key":"10.1016\/j.brainres.2011.02.079_bb0215","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-3-540-74806-9_11","article-title":"Propofol","author":"Vanlersberghe","year":"2008","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.brainres.2011.02.079_bb0220","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-2094-3-6","article-title":"Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease","volume":"3","author":"Vijitruth","year":"2006","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.brainres.2011.02.079_bb0225","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1096\/fj.04-2457fje","article-title":"MPP+-induced COX-2 activation and subsequent dopaminergic neurodegeneration","volume":"19","author":"Wang","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.brainres.2011.02.079_bb0230","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jns.2009.06.034","article-title":"JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease","volume":"285","author":"Wang","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.brainres.2011.02.079_bb0235","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0197-4580(01)00282-2","article-title":"Cyclooxygenase (COX)-2 and cell cycle activity in a transgenic mouse model of Alzheimer's disease neuropathology","volume":"23","author":"Xiang","year":"2002","journal-title":"Neurobiol. Aging"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899311004355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899311004355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T05:07:44Z","timestamp":1592370464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899311004355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":48,"alternative-id":["S0006899311004355"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2011.02.079","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}